Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.61
+1.01 (8.71%)
Aug 19, 2026, 9:57 AM EDT - Market open
Intellia Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 106.13 | 155.46 | 189.18 | 226.75 | 523.51 | 123.41 |
Short-Term Investments | 331.63 | 294.42 | 412.33 | 685.48 | 669.12 | 625.28 |
Cash & Short-Term Investments | 437.76 | 449.88 | 601.52 | 912.22 | 1,193 | 748.69 |
Cash Growth | -4.76% | -25.21% | -34.06% | -23.51% | 59.29% | 25.33% |
Receivables | 7.32 | 9.47 | 8.52 | 36.46 | 3.77 | 2.03 |
Prepaid Expenses | 82.75 | 68.36 | 29.83 | 47.55 | 20.41 | 18.58 |
Other Current Assets | - | - | - | 2.1 | - | - |
Total Current Assets | 527.83 | 527.71 | 639.86 | 998.33 | 1,217 | 769.3 |
Property, Plant & Equipment | 101.01 | 123.63 | 246.67 | 148.14 | 161 | 100.11 |
Long-Term Investments | 212.48 | 177.71 | 287.09 | 136.39 | 126.59 | 420.29 |
Other Long-Term Assets | 15.84 | 13.08 | 17.39 | 18.12 | 15.73 | 4.76 |
Total Assets | 857.16 | 842.13 | 1,191 | 1,301 | 1,520 | 1,294 |
Accounts Payable | 11.71 | 20.25 | 14.59 | 7.45 | 5.15 | 9.65 |
Accrued Expenses | 44.33 | 49.86 | 55.36 | 60.13 | 60.88 | 43.31 |
Current Portion of Leases | 23.34 | 26.48 | 20.25 | 18.6 | 16.69 | 9.11 |
Current Unearned Revenue | - | 7.29 | 20.66 | 22.14 | 43.84 | 63.76 |
Other Current Liabilities | - | - | - | 6.89 | - | - |
Total Current Liabilities | 79.39 | 103.88 | 110.85 | 115.21 | 126.55 | 125.83 |
Long-Term Leases | 50.07 | 66.85 | 189.95 | 96.75 | 114.02 | 64.91 |
Long-Term Unearned Revenue | - | - | 18.26 | 38.85 | 19.93 | 63.48 |
Other Long-Term Liabilities | - | - | - | - | 24.03 | - |
Total Liabilities | 129.46 | 170.73 | 319.06 | 250.81 | 284.53 | 254.22 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 3,522 | 3,260 | 3,049 | 2,711 | 2,420 | 1,746 |
Retained Earnings | -2,793 | -2,590 | -2,177 | -1,658 | -1,177 | -703 |
Comprehensive Income & Other | -1.03 | 1.03 | 0.61 | -2.26 | -7.46 | -2.63 |
Total Common Equity | 727.71 | 671.39 | 871.96 | 1,050 | 1,236 | 1,040 |
Shareholders' Equity | 727.71 | 671.39 | 871.96 | 1,050 | 1,236 | 1,040 |
Total Liabilities & Equity | 857.16 | 842.13 | 1,191 | 1,301 | 1,520 | 1,294 |
Total Debt | 73.41 | 93.33 | 210.2 | 115.35 | 130.7 | 74.02 |
Net Cash (Debt) | 554.94 | 511.81 | 651.53 | 896.74 | 1,131 | 1,012 |
Net Cash Growth | 5.12% | -21.45% | -27.34% | -20.73% | 11.78% | 81.34% |
Net Cash Per Share | 4.64 | 4.72 | 6.59 | 10.10 | 14.70 | 14.28 |
Filing Date Shares Outstanding | 140.13 | 118.13 | 103.52 | 96.11 | 88.02 | 74.67 |
Total Common Shares Outstanding | 140.02 | 116.32 | 102.03 | 93 | 87.1 | 74.49 |
Working Capital | 448.44 | 423.83 | 529.01 | 883.12 | 1,090 | 643.47 |
Book Value Per Share | 5.20 | 5.77 | 8.55 | 11.29 | 14.19 | 13.97 |
Tangible Book Value | 727.71 | 671.39 | 871.96 | 1,050 | 1,236 | 1,040 |
Tangible Book Value Per Share | 5.20 | 5.77 | 8.55 | 11.29 | 14.19 | 13.97 |
Machinery | - | 71.16 | 71.97 | 67.59 | 56.33 | 43.34 |
Leasehold Improvements | - | 3.2 | 3.2 | 3.13 | 3.07 | 2.19 |